Outcomes Data of Adipose Stem Cells to Treat Rheumatoid Arthritis
Status: | Recruiting |
---|---|
Conditions: | Arthritis, Rheumatoid Arthritis |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 9/2/2018 |
Start Date: | January 2015 |
End Date: | May 2019 |
Contact: | Holly Bergen |
Phone: | 800-609-7795 |
Autologous Adipose Stromal Vascular Fraction Outcomes in Rheumatoid Arthritis Research Study
The purpose of this study is to determine the impact that treatment with a cellular
concentrate derived from an individual's own fat, known as the stromal vascular fraction
(SVF), has on pain and functionality in people with rheumatoid arthritis (RA). SVF contains
multiple cellular components, including stem cells, with both regenerative and
anti-inflammatory properties. This therapy has shown promise for ameliorating the symptoms of
RA. This study is designed to evaluate changes in pain and functionality in individuals with
RA for up to 12 months following SVF treatment.
concentrate derived from an individual's own fat, known as the stromal vascular fraction
(SVF), has on pain and functionality in people with rheumatoid arthritis (RA). SVF contains
multiple cellular components, including stem cells, with both regenerative and
anti-inflammatory properties. This therapy has shown promise for ameliorating the symptoms of
RA. This study is designed to evaluate changes in pain and functionality in individuals with
RA for up to 12 months following SVF treatment.
Inclusion Criteria:
- Subjects diagnosed with rheumatoid arthritis
- Subjects scheduled for a stem cell/SVF treatment
- Subjects willing and able to sign informed consent
- Subjects willing and able to perform follow-up interviews and surveys
Exclusion Criteria:
- Subjects with addition major health condition/disease diagnoses
- Subjects that are pregnant or breastfeeding
We found this trial at
1
site
Click here to add this to my saved trials
